TXA is increasingly used in otolaryngology to reduce intra-operative and post-operative bleeding, supported by evidence from emergency medicine and orthopedic surgery. Its safety profile is strong, and it is administered intravenously or orally, with emerging use in pediatric and adult otolaryngologic procedures.
Dr. Lindsay emphasizes the importance of reconnecting, recharging, and choosing joy in the face of the professional and personal challenges faced by otolaryngologists. She highlights the importance of authentic connections and intentional self-care during challenging times.
AI is increasingly integrated into otolaryngology, offering practical benefits in clinical settings while also highlighting current limitations in surgical and patient communication contexts.
Mentorship, sponsorship, and coaching are distinct but complementary roles essential for career development in academic medicine. Each plays a unique role in supporting physicians and scientists at different stages of their careers.
CMS’s Interoperability and Prior Authorization Final Rule becomes effective January 1, 2026. What does this mean for ENT surgeons?
Navigating new rules and persistent challenges in prior authorization for surgery
ENT leaders share hopes, innovations, and inspirations shaping the future of ENT
Evidence supporting the addition of antivirals to corticosteroids in Bell’s palsy is statistically fragile. Across randomized controlled trials (RCTs), only a few patient outcome reversals would nullify reported significance, suggesting current conclusions about combination therapy lack robustness.
Radiotherapy achieved durable tumor control in most growing vestibular schwannomas, with outcomes unaffected by pre-treatment tumor size or location.
Nearly half of children with 22qDS exhibited ICA medialization on imaging, with one in five needing a change in the surgical plan. Despite many authors advocating for routine imaging, its universal use is uncertain due to high study heterogeneity and limited outcome data.